Skip to main content

Improved diagnosis of cancer patients by novel dualistic histology methods

Objective

Pharmacogenomics is an emerging discipline with a great potential for improving future clinical care. The linkage between the knowledge of treatment outcome and the underlying molecular alteration constitutes the principle of pharmacogenomics. The recent d evelopments of Herceptin (targeting the HER2 oncoprotein in breast cancer) and Glivec (targeting the BCR-ABL translocation in leukaemia) have demonstrated a close relationship between the molecular alteration and the clinical response. The success of these treatments has depended absolutely upon the development of appropriate clinical diagnostic tests (pharmacodiagnostics) to identify those patients, who are most likely to benefit from the treatment. The main objective of the proposed industry-academia part nership is to develop newpharmacodiagnostics to improve the selection of patients for targeted cancer therapies. DakoCytomation is a company at the forefront of the development of pharmacodiagnostics as evidenced by their strong involvement in ER and HER2. Dr. Bartlett research group at Glasgow University has achieved a unique expert position by combining translational research with histopathological evaluation of novel targeted cancer therapies tested by the pharmaceutical industry in European clinical tri als. Through exchange of experienced researchers, it is the intention to extend substantially the existing collaboration between DakoCytomation and Dr. Bartlett research group. This efficient way of combining complementary skills makes the objective very r ealistic. The new pharmacodiagnostic assays will be based on a) combining and optimising existing detection principles, b) combining detection of existing and/or novel markers on the same specimens and c) identifying new diseases/therapy indications for ex isting and optimised assays.

Call for proposal

FP6-2002-MOBILITY-3
See other projects for this call

Funding Scheme

TOK - Marie Curie actions-Transfer of Knowledge

Coordinator

DAKOCYTOMATION DENMARK A/S
Address
Produktionsvej, 42
Glostrup
Denmark

Participants (1)

UNIVERSITY OF GLASGOW.
United Kingdom
Address
University Avenue
Glasgow